Ekso Bionics (NASDAQ: EKSO) reported Q4 EPS of ($0.24), $0.02 worse than the analyst estimate of ($0.22). Revenue for the quarter came in at $3.6 million versus the consensus estimate of $3.94 million.

For earnings history and earnings-related data on Ekso Bionics (EKSO) click here.